MAZZEO, Anna
 Distribuzione geografica
Continente #
NA - Nord America 14.732
EU - Europa 13.483
AS - Asia 7.941
SA - Sud America 2.686
Continente sconosciuto - Info sul continente non disponibili 615
AF - Africa 250
OC - Oceania 13
Totale 39.720
Nazione #
US - Stati Uniti d'America 14.267
RU - Federazione Russa 6.548
SG - Singapore 3.664
BR - Brasile 2.271
CN - Cina 2.055
IE - Irlanda 1.706
SE - Svezia 1.168
IT - Italia 1.110
HK - Hong Kong 786
DE - Germania 719
FI - Finlandia 480
FR - Francia 473
VN - Vietnam 438
UA - Ucraina 409
PL - Polonia 289
GB - Regno Unito 273
IN - India 221
CA - Canada 183
BD - Bangladesh 166
AR - Argentina 156
MX - Messico 99
TR - Turchia 82
EC - Ecuador 71
ID - Indonesia 67
ZA - Sudafrica 67
IQ - Iraq 65
NL - Olanda 57
MA - Marocco 51
CO - Colombia 49
UZ - Uzbekistan 47
PK - Pakistan 46
BE - Belgio 45
JP - Giappone 44
AT - Austria 40
ES - Italia 39
VE - Venezuela 37
CL - Cile 34
LT - Lituania 32
CI - Costa d'Avorio 29
IL - Israele 29
PY - Paraguay 25
KE - Kenya 24
PE - Perù 24
JM - Giamaica 22
PH - Filippine 22
HN - Honduras 21
NI - Nicaragua 21
AZ - Azerbaigian 20
CR - Costa Rica 20
SA - Arabia Saudita 20
TN - Tunisia 19
NP - Nepal 18
AE - Emirati Arabi Uniti 16
GT - Guatemala 15
TT - Trinidad e Tobago 15
CZ - Repubblica Ceca 14
EU - Europa 14
JO - Giordania 14
KZ - Kazakistan 14
AL - Albania 13
MY - Malesia 13
DZ - Algeria 12
PR - Porto Rico 12
TH - Thailandia 12
DO - Repubblica Dominicana 11
KR - Corea 10
RO - Romania 10
AU - Australia 9
BO - Bolivia 9
CW - ???statistics.table.value.countryCode.CW??? 9
EG - Egitto 9
KG - Kirghizistan 9
LB - Libano 9
SV - El Salvador 9
UY - Uruguay 9
RS - Serbia 8
SC - Seychelles 8
CH - Svizzera 7
IR - Iran 7
PA - Panama 7
PS - Palestinian Territory 7
EE - Estonia 6
GP - Guadalupe 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
GA - Gabon 5
GR - Grecia 5
LA - Repubblica Popolare Democratica del Laos 5
LK - Sri Lanka 5
OM - Oman 5
SN - Senegal 5
AM - Armenia 4
BB - Barbados 4
BH - Bahrain 4
ET - Etiopia 4
KW - Kuwait 4
AO - Angola 3
BS - Bahamas 3
BW - Botswana 3
DM - Dominica 3
Totale 39.065
Città #
Ashburn 2.185
Moscow 2.144
Dublin 1.700
Singapore 1.561
Dallas 1.393
Chandler 1.110
Jacksonville 862
San Jose 807
Hong Kong 782
Nyköping 752
Beijing 705
Council Bluffs 533
The Dalles 371
Messina 347
Princeton 299
Los Angeles 292
Munich 292
Warsaw 281
Lauterbourg 277
Medford 271
Cambridge 234
Des Moines 219
Ann Arbor 181
Dearborn 176
New York 168
São Paulo 159
Ho Chi Minh City 158
Buffalo 150
Helsinki 149
Santa Clara 107
Boardman 103
Tianjin 98
Phoenix 78
Wilmington 78
Orem 76
Guangzhou 75
Turku 75
Hanoi 71
Rio de Janeiro 71
Redondo Beach 67
San Mateo 67
Jinan 65
Belo Horizonte 61
Shenyang 60
Brooklyn 57
Houston 57
Bremen 52
Atlanta 51
Pune 47
Woodbridge 47
Brasília 46
Chicago 46
Montreal 46
Rome 44
San Francisco 44
Tashkent 44
Frankfurt am Main 43
Hyderabad 43
Lancaster 43
Chennai 42
Shanghai 39
Seattle 38
Columbus 37
Curitiba 36
Milan 36
Nanjing 36
Tokyo 36
Denver 35
London 35
Shenzhen 33
Ningbo 32
Nuremberg 32
Porto Alegre 32
Hebei 31
Johannesburg 31
Brussels 30
Hangzhou 30
Zhengzhou 30
Abidjan 29
Lawrenceville 29
Mexico City 29
Toronto 29
Guayaquil 27
Mumbai 27
Baghdad 26
Boston 26
Catania 26
Salvador 26
Amsterdam 25
Dhaka 25
Haikou 25
Lappeenranta 25
Manchester 25
Quito 25
Palermo 24
Campinas 23
Istanbul 23
Jakarta 23
Nairobi 23
Norwalk 22
Totale 21.633
Nome #
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 745
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 375
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 355
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 345
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 345
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 297
Value of 99mTc-DPD scintigraphy as early diagnostic modality in familial amyloidotic polyneuropathy. 282
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 271
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease 264
Clinical and pathological features of focal myositis 258
A CMT1A PATIENT WITH PAINFUL AND DISABLING SYMPTOMS: FAST RECOVERY AFTER IVIG TREATMENT. 257
Etanercept for psoriasis and psoriatic arthritis in a patient with Charcot-Marie-Tooth disease 256
A Nouvel serum MicroRNA signature to screen ATTR 239
Behaviour of vinculin and talin in perineurial cells in healthy subjects and in subjects affected by diabteic neuropathy 233
2D Feature Strain Echocardiography in patients with transthyretin familial amyloid plyneuropathy and diffuse cardiac 99mTc-DPD accumulation 230
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 228
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 228
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 223
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 210
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 205
"Dropped- head" syndrome due to isolated myositis of neck extensor muscles: MRI findings 204
Dolori muscolari, deficit di forza e/o disturbi sensitivi 204
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 204
A novel mutation in KIF5A gene causing hereditary spastic paraplegia with axonal neuropathy. 203
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 193
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 191
Comparison Between 99mTc-Diphosphonate Imaging and MRI With Late Gadolinium Enhancement in Evaluating Cardiac Involvement in Patients With Transthyretin Familial Amyloid Polyneuropathy 190
ANT1 is reduced in sporadic inclusion body myositis. 187
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 187
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 183
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 182
Is overwork weakness relevant in Charcot-Marie-Tooth disease? 182
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 181
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 181
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 179
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 178
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 178
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 177
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 177
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 176
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 176
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy 174
A novel Cx32 mutation with unusual phenotype. 174
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial 173
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 172
Coinvolgimento Cardiaco in Pazienti con Polineuropatia Amiloidotica Familiare: Dimostrazione Precoce con Cardio-Rm 170
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 168
A novel Cx32 mutation with unusual phenotype 167
Are novel outcome measures for Charcot–Marie–Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study 167
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 166
A NOVEL MUTATION IN KIF5A GENE CAUSING HEREDITARY SPASTIC PARAPLEGIA WITH AXONAL NEUROPATHY; 165
Dolori muscolari, deficit di forza e/o disturbi sensitivi 165
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 165
Clinical and genotype characteristics and symptom migration in patients with mixed phenotype transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey 163
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 163
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 161
Cardiac involvement in transthyretin familial amyloid polyneuropathy - comparison between 99mTc-DPD SPECT and magnetic resonance imaging 161
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 160
Acquired idiopathic generalized anhidrosis: a case report 159
A novel CX32 mutation with unusual phenotype 158
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 158
Nerve conduction velocity in CMT1A: what else can we tell? 157
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis 157
Correlation between semiquantitative analysis of 99mTc-DPD scintigraphy and clinical scores in patients with familial amyloidotic polyneuropathy 156
Activation and localization of transcription factor NF-KB in peripheral neuropathies of different origin. 156
Mid-basal left ventricular longitudinal dysfunction as a prognostic marker in mutated transthyretin-related cardiac amyloidosis 155
Acquired idiopathic generalized anhidrosis: a case report 154
Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association 153
Charcot-Marie-Tooth type X: unusual phenotype of a novel CX32 mutation 152
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 152
Amyloid myopathy presenting with rhabdomyolysis: evidence of complement activation. 151
Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: data from the national CMT registry 149
Bilateral symmetrical peroneal neuropathy: rapid recovery after IVIG. 149
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 148
Amyloid myopathy presenting with rhabdomyolysis 147
Atrial function in cardiac amyloidosis: a 2d-strain echocardiography and cardiac MRI study 147
Bilateral symmetrical peroneal neuropathy: rapid recovery after IVIG 145
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). 145
Cardiac Involvement in Patients with Family Amyloid Polyneuropathy: Early Demostration with Cardiac Magnetic Resonance 144
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 143
LOCALIZATION OF VINCULIN AND TALIN AT PERINEURIAL CELLS OF HUMAN SURAL NERVE 142
Atypical rat cerebellar immunoreactivity in a patient with familial amyloid polyneuropathy. 142
Amyloid myopathy presenting with rhabdomyolisis: evidence of complement activation. 141
Quantitative comparison between amyloid deposition detected by 99mTC-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin-related cardiac amyloidosis 141
MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy 140
AUTONOMIC DYSFUNCTION AND HEART INVOLVEMENT IN TRANSTHYRETIN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY 140
Unilateral hyperhidrosis as persistently isolated feature of syringomyelia and Arnold Chiari type 1 140
Considerable post-partum worsening in a patient with CMT2E 139
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 139
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 139
Amyloid myopathy presenting with rhabdomyolysis. 138
Behaviour of Vinculin and Talin in Perineurial Cells in Healthy Subjects and in Subjects Affected by Diabetic Neuropathy. 138
Early Impairment of Right Ventricular Morphology and Function in Transthyretin-Related Cardiac Amyloidosis 138
Atypical rat cerebellar immunoreactivity in a patient with familial amyloid polyneuropathy. 137
Facial onset sensory motor neuronopathy: not always a slowly progressive disorder. 137
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 137
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 136
Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene Mutation 136
Dp116, talin, vinculin and vimentin immunoreactivities following nerve transection 135
Autoimmune polyglandular disease (APECED) and mutineuropathy: a case report 135
Totale 18.698
Categoria #
all - tutte 137.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.344 0 0 0 0 97 15 135 86 41 95 204 671
2022/20234.505 387 389 219 308 317 415 46 250 2.017 22 102 33
2023/20241.090 79 184 92 73 94 251 26 69 5 72 13 132
2024/20256.750 130 61 95 361 284 315 307 1.288 1.529 336 827 1.217
2025/202617.020 802 1.259 1.504 1.320 1.374 3.566 1.956 1.945 1.928 724 303 339
2026/20274.003 750 1.151 794 1.302 6 0 0 0 0 0 0 0
Totale 39.720